Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.

Diabetologia
Sunny S SinghMandy van Hoek

Abstract

Microvascular disease in type 2 diabetes is a significant cause of end-stage renal disease, blindness and peripheral neuropathy. The strict control of known risk factors, e.g. lifestyle, hyperglycaemia, hypertension and dyslipidaemia, reduces the incidence of microvascular complications, but a residual risk remains. Lipoprotein (a) [Lp(a)] is a strong risk factor for macrovascular disease in the general population. We hypothesised that plasma Lp(a) levels and the LPA gene SNPs rs10455872 and rs3798220 are associated with the incident development of microvascular complications in type 2 diabetes. Analyses were performed of data from the DiaGene study, a prospective study for complications of type 2 diabetes, collected in the city of Eindhoven, the Netherlands (n = 1886 individuals with type 2 diabetes, mean follow-up time = 6.97 years). To assess the relationship between plasma Lp(a) levels and the LPA SNPs with each newly developed microvascular complication (retinopathy n = 223, nephropathy n = 246, neuropathy n = 236), Cox proportional hazards models were applied and adjusted for risk factors for microvascular complications (age, sex, mean arterial pressure, non-HDL-cholesterol, HDL-cholesterol, BMI, duration of type 2 diabet...Continue Reading

References

Feb 1, 1992·Atherosclerosis·N RifaiK Doetsch
Oct 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C SandholzerG Utermann
Aug 1, 1987·The Journal of Clinical Investigation·G UtermannC Seitz
Dec 1, 1988·Physical Therapy·D S SimsJ S Ulbrecht
Aug 26, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D L Rainwater, S M Haffner
Aug 10, 1999·Scandinavian Journal of Primary Health Care·P E Wändell
Dec 21, 2000·Current Atherosclerosis Reports·J D Morrisett
Feb 8, 2006·Postgraduate Medical Journal·V BansalU K Misra
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Apr 26, 2007·Indian Journal of Ophthalmology·Rupali ChopraAbraham Rebecca
Oct 11, 2007·Diabetes, Obesity & Metabolism·Andrew J KrentzChristopher D Byrne
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Pia R KamstrupBørge G Nordestgaard
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Nov 13, 2009·Diabetes Care·Simon R Heller, UNKNOWN ADVANCE Collaborative Group
Nov 10, 2009·Behavior Research Methods·Franz FaulAlbert-Georg Lang
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Jun 11, 2011·Journal of Lipids·Dipanjan BanerjeeLatha Palaniappan
May 31, 2012·World Journal of Diabetes·Radhakrishnan Chandni, Kollengode Parameswaran Ramamoorthy
Sep 25, 2012·Journal of Internal Medicine·F Kronenberg, G Utermann
Apr 18, 2014·Nature Reviews. Genetics·Pak C Sham, Shaun M Purcell
Aug 12, 2014·The Lancet Global Health·Rupert R A BourneUNKNOWN Vision Loss Expert Group
Jul 24, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·J-S YunS-H Ko
Dec 8, 2015·Journal of Lipid Research·Santica M Marcovina, John J Albers
Dec 8, 2015·Journal of Lipid Research·Byambaa EnkhmaaLars Berglund
Feb 21, 2016·Cardiovascular Drugs and Therapy·Florian Kronenberg
Mar 5, 2016·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Hamid Nasri, Mahmoud Rafieian-Kopaei
Mar 8, 2016·Journal of Diabetes and Its Complications·Hidenori SenbaYoshihiro Miyake
Apr 9, 2016·Journal of Clinical Lipidology·Jae-Seung YunSeung-Hyun Ko
Apr 15, 2016·Journal of Lipid Research·Konrad SchmidtGerd Utermann
Jan 28, 2017·Current Pharmaceutical Design·Julia Schreml, Ioanna Gouni-Berthold
Apr 4, 2017·The Lancet. Diabetes & Endocrinology·Sophia ZoungasUNKNOWN Collaborators on Trials of Lowering Glucose (CONTROL) group
May 5, 2017·The Journal of Clinical Endocrinology and Metabolism·Wen-Jun TuMin Guo

❮ Previous
Next ❯

Citations

May 1, 2020·Journal of Diabetes and Its Complications·Niels Sondergaard HeinrichPeter Rossing

❮ Previous
Next ❯

Software Mentioned

R
DiaGene
SPSS
mgcv

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Diabète & Métabolisme
O ZieglerP Drouin
Expert Opinion on Therapeutic Targets
Marlys L Koschinsky, Michael B Boffa
BMJ : British Medical Journal
© 2021 Meta ULC. All rights reserved